Baebies was selected as the winner of the AACC Disruptive Technology Award by a panel of expert judges at the virtual 2020 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo, according to a press release.
During the virtual competition, Baebies, which develops newborn testing tools, presented FINDER, a near-patient testing platform featuring a toaster-sized instrument and disposable cartridge. Powered by digital microfluidics technology, FINDER tests for diseases from low sample volume with a turn-around time of approximately 15 minutes after sample introduction.
FINDER received CE Mark in December 2019 as an in vitro diagnostic device (IVD) and is commercially available in Europe and other countries that recognize CE Mark. FINDER is not currently available for sale in the United States.
Digital microfluidics (DMF) is a method to manipulate separate droplets of liquid by electrical control of surface tension, or electrowetting, to perform bioassay protocols. DMF enables quick precision handling of discrete droplets on FINDER’s disposable cartridge – which is completely self-contained with all reagents on board. Baebies’ technology is protected by more than a hundred patents.
Digital microfluidics supports multifunctional assay methods – including molecular, immunoassay, and chemistry – on the same cartridge.
